- Home
- KZR vs POCI Comparison
KZR vs POCI Comparison
Compare KZR & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- POCI
- Stock Information
- Founded
- KZR 2015
- POCI 1982
- Country
- KZR United States
- POCI United States
- Employees
- KZR N/A
- POCI N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KZR Health Care
- POCI Health Care
- Exchange
- KZR Nasdaq
- POCI Nasdaq
- Market Cap
- KZR 29.7M
- POCI 35.1M
- IPO Year
- KZR 2018
- POCI N/A
- Fundamental
- Price
- KZR $3.78
- POCI $4.65
- Analyst Decision
- KZR Hold
- POCI
- Analyst Count
- KZR 2
- POCI 0
- Target Price
- KZR $9.00
- POCI N/A
- AVG Volume (30 Days)
- KZR 34.3K
- POCI 4.0K
- Earning Date
- KZR 11-11-2025
- POCI 11-13-2025
- Dividend Yield
- KZR N/A
- POCI N/A
- EPS Growth
- KZR N/A
- POCI N/A
- EPS
- KZR N/A
- POCI N/A
- Revenue
- KZR N/A
- POCI $17,626,155.00
- Revenue This Year
- KZR N/A
- POCI N/A
- Revenue Next Year
- KZR N/A
- POCI N/A
- P/E Ratio
- KZR N/A
- POCI N/A
- Revenue Growth
- KZR N/A
- POCI N/A
- 52 Week Low
- KZR $3.62
- POCI $3.47
- 52 Week High
- KZR $9.18
- POCI $6.59
- Technical
- Relative Strength Index (RSI)
- KZR 37.60
- POCI 51.79
- Support Level
- KZR $3.76
- POCI $4.15
- Resistance Level
- KZR $4.05
- POCI $4.55
- Average True Range (ATR)
- KZR 0.13
- POCI 0.17
- MACD
- KZR 0.00
- POCI -0.01
- Stochastic Oscillator
- KZR 5.13
- POCI 61.33
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.